NCT01526369 2025-05-09
TH V THL
Cancer Trials Ireland
Phase 3 Completed
Clinical Trials
8 trialsNCT00424164 2024-03-08
LAPATAM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT01138384 2023-08-04
Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
Canadian Cancer Trials Group
Phase 1/2 Completed
NCT01485926 2018-08-06
TCHL Phase II
Cancer Trials Ireland
Phase 2 Completed
NCT00450892 2016-07-07
Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1/2 Completed
NCT00486668 2016-06-06
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
NSABP Foundation Inc
Phase 3 Unknown
NCT00753207 2016-02-15
Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30
Cancer Trials Ireland
Phase 1 Completed
NCT01495884 2015-10-26
The Myocet/Lapatinib Study. ICORG 10-03, V5
Cancer Trials Ireland
Phase 1/2 Terminated